WATERS CORP /DE/
Close on Oct 19, 2026
- Market cap
- $42.65T
- P/E (TTM)
- 108.3
- Dividend yield
- –
Earnings
Next report expected Nov 3, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jul 4, 2026 | Aug 4, 2026 | Before market open | $1.65B | $-1.39 | $3.05 |
| Q1 FY2026 Ended Apr 4, 2026 | May 5, 2026 | Before market open | $1.27B | $-0.87 | $2.70 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 9, 2026 | Before market open | $932.00M | $3.77 | $4.53 |
| Q3 FY2025 Ended Sep 27, 2025 | Nov 4, 2025 | Before market open | $800.00M | $2.50 | $3.40 |
| Q2 FY2025 Ended Jun 28, 2025 | Aug 4, 2025 | Before market open | $771.00M | $2.47 | $2.95 |
| Q1 FY2025 Ended Mar 29, 2025 | May 6, 2025 | Before market open | $662.00M | $2.03 | $2.25 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 12, 2025 | Before market open | $873.00M | $3.88 | $4.10 |
| Q3 FY2024 Ended Sep 28, 2024 | Nov 1, 2024 | Before market open | $740.00M | $2.71 | $2.93 |
| Q2 FY2024 Ended Jun 29, 2024 | Jul 31, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 30, 2024 | May 7, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 6, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 4, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted EPSnon-GAAP | full-year 2026 | $14.45 to $14.65 | Raised |
| adjusted EPSnon-GAAP | third quarter 2026 | $3.95 to $4.05 | New |
| organic constant currency revenue growthnon-GAAP | full-year 2026 | 7% to 9% growth | New |
| organic constant currency revenue growthnon-GAAP | third quarter 2026 | 8% to 10% growth | New |
| organic reported revenueGAAP | full-year 2026 | $3.37B to $3.43B | Lowered |
| acquired business reported revenueGAAP | full-year 2026 | $3.05B | Lowered |
| Total Company reported revenueGAAP | full-year 2026 | $6.42B to $6.48B | Raised |
| organic reported revenueGAAP | third quarter 2026 | $850.00M to $867.00M | New |
| acquired business reported revenueGAAP | third quarter 2026 | $895.00M | Raised |
| Total Company reported revenueGAAP | third quarter 2026 | $1.75B to $1.76B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Waters filed with the SEC
Waters Corporation (NYSE: WAT) Reports Second Quarter 2026
Results of operations · EX-99.1 to Form 8-K
Head of Investor Relations – (508) 482-3448
Results of operations · EX-99.1 to Form 8-K
INDEX TO CONDENSED COMBINED FINANCIAL STATEMENTS
Other events · EX-99.1 to Form 8-K
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
Other events · EX-99.2 to Form 8-K
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
Other events · EX-99.3 to Form 8-K
Waters Completes Combination with BD’s Biosciences & Diagnostic Solutions Businesses
Material agreement · Acquisition or disposition completed · New financial obligation · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INDEX TO COMBINED FINANCIAL STATEMENTS
Material agreement · Acquisition or disposition completed · New financial obligation · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Material agreement · Acquisition or disposition completed · New financial obligation · Executive or director change · Regulation FD disclosure · EX-99.3 to Form 8-K
Waters Corporation (NYSE: WAT) Reports Fourth Quarter
Results of operations · EX-99.1 to Form 8-K
Waters Shareholders Approve Combination with BD’s Biosciences & Diagnostic Solutions Business
Shareholder vote results · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
J.P. Morgan 44th Annual Healthcare
Regulation FD disclosure · EX-99.1 to Form 8-K
Waters Corporation (NYSE: WAT) Reports Third Quarter 2025
Results of operations · EX-99.1 to Form 8-K
Waters Corporation (NYSE: WAT) Reports Second Quarter 2025
Results of operations · EX-99.1 to Form 8-K
Waters and BDs Biosciences & Diagnostic Solutions Business to Combine,
Regulation FD disclosure · EX-99.1 to Form 8-K
Science Tools & Diagnostics Leader Focused on Regulated, High-Volume Testing July 14, 2025
Regulation FD disclosure · EX-99.2 to Form 8-K
Investor Relations (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Caspar Tudor, Head of Investor Relations (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Ph.D. President & CEO January 13, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Waters Corporation (NYSE: WAT) Reports Third Quarter 2024
Results of operations · EX-99.1 to Form 8-K
Corporation Appoints Heather Knight to
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Investor Relations (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Investor Relations (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Caspar Tudor, Head of Investor Relations (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Ph.D. President & CEO January 8, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
Investor Relations (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Corporation Announces Business Unit Leadership Transition
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Waters Corporation (NYSE: WAT) Reports Second Quarter 2023
Results of operations · EX-99.1 to Form 8-K
Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Caspar Tudor, Head of Investor Relations – (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Waters Corporation Appoints Richard Fearon
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Tudor, Head of Investor Relations – (508) 482-2429
Material agreement · Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader
Material agreement · Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
J.P. Morgan 41st Annual Healthcare Conference Udit Batra, Ph.D. President & CEO January 9,
Regulation FD disclosure · EX-99.1 to Form 8-K
Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Tudor, Head of Investor Relations – (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Tudor, Head of Investor Relations – (508) 482-2429
Results of operations · Executive or director change · EX-99.1 to Form 8-K
2022 Analyst & Investor Day May 19, 2022 watersTM
Regulation FD disclosure · EX-99.1 to Form 8-K
Investor Relations – (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Investor Relations – (508) 482-2429
Results of operations · EX-99.1 to Form 8-K
Udit Batra, Ph.D. President & CEO
Regulation FD disclosure · EX-99.1 to Form 8-K